参考文献/References:
[1] Wang L, Lee YK, Bundman D, et al. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell, 2002, 2(6): 721-731.
[2] Jain AK, Stoll B, Burrin DG, et al. Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs. Am J Physiol Gastrointest Liver Physiol, 2012, 302(2): G218-G224.
[3] Yasuda H, Hirata S, Inoue K, et al. Involvement of membrane type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen activated protein kinases in gastric carcinoma cells. Biochem Biophys Res Commun, 2007, 354(1): 154-159.
[4] Pellicciari R, Sato H, Gioiello A, et al. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6, 23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. J Med Chem, 2007, 50(18): 4265-4268.
[5] Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology, 1996, 111(1): 193-198.
[6] Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res, 2007,24(10): 1803-1823.
[7] Feng Y, Sun X, Yang H, et al. Dissociation of E-cadherin and β-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy. J Physiol, 2009, 587(3): 641-654.
[8] Yan JK, Yan WH, Cai W. Fish oil-derived lipid emulsion induces RIP1-dependent and caspase 8-licensed necroptosis in IEC-6 cells through overproduction of reactive oxygen species. Lipids Health Dis, 2018, 17(1): 148.
[9] 王 鑫, 张萌萌, 姜 宁, 等. 宿主防御肽调节动物肠道屏障功能的研究进展. 动物营养学报, 2018, 30(9): 3410-3416.
[10] Sun X, Yang H, Nose K, et al. Decline in intestinal mucosal IL-10 expression and decreased intestinal barrier function in a mouse model of total parenteral nutrition. Am J Physiol Gastrointest Liver Physiol, 2008, 294(1): G139-147.
[11] Liu Y, Gong Z, Zhou J, et al. Lin 28A/Occludin axis: An aberrantly activated pathway in intestinal epithelial cells leading to impaired barrier function under total parenteral nutrition. Faseb j, 2021,35(2):e21189.
[12] Zhang T, Liu Y, Yan JK, et al. Early downregulation of P glycoprotein facilitates bacterial attachment to intestinal epithelial cells and thereby triggers barrier dysfunction in a rodent model of total parenteral nutrition. Faseb j, 2020, 34(3): 4670-4683.
[13] Burcelin R, Serino M, Chabo C, et al. Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes Obes Metab, 2013, 15 Suppl 3: 61-70.
[14] Kverka M, Tlaskalová-Hogenová H. Intestinal Microbiota: Facts and Fiction. Dig Dis, 2017, 35(1-2): 139-147.
[15] Pierre JF. Gastrointestinal immune and microbiome changes during parenteral nutrition. Am J Physiol Gastrointest Liver Physiol, 2017, 312(3): G246-G256.
[16] David R. Regulatory T cells: A helping hand from Bacteroides fragilis. Nat Rev Immunol, 2010, 10(8): 539.
[17] Cahova M, Bratova M, Wohl P. Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota. Nutrients, 2017, 9(9):987.
[18] Denning TL, Norris BA, Medina-Contreras O, et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol, 2011, 187(2): 733-747.
[19] Rivollier A, He J, Kole A, et al. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med, 2012, 209(1): 139-155.
[20] Ochi T, Feng Y, Kitamoto S, et al. Diet-dependent, microbiota independent regulation of IL-10-producing lamina propria macrophages in the small intestine. Sci Rep, 2016, 6: 27634.
[21] Omata J, Pierre JF, Heneghan AF, et al. Parenteral nutrition suppresses the bactericidal response of the small intestine. Surgery, 2013, 153(1): 17-24.
[22] Pierre JF, Heneghan AF, Tsao FH, et al. Route and type of nutrition and surgical stress influence secretory phospholipase A2 secretion of the murine small intestine. JPEN J Parenter Enteral Nutr, 2011, 35(6): 748-756.
[23] Van der Sluis M, De Koning BA, De Bruijn AC, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology, 2006,131(1): 117-129.
[24] Wang X, Pierre JF, Heneghan AF, et al. Glutamine Improves Innate Immunity and Prevents Bacterial Enteroinvasion During Parenteral Nutrition. JPEN J Parenter Enteral Nutr, 2015, 39(6):688-697.
[25] Heneghan AF, Pierre JF, Gosain A, et al. IL-25 improves luminal innate immunity and barrier function during parenteral nutrition. Ann Surg, 2014, 259(2): 394-400.
[26] Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res, 2006, 47(2): 241-259.
[27] Jia ET, Liu ZY, Pan M, et al. Regulation of bile acid metabolism related signaling pathways by gut microbiota in diseases. J Zhejiang Univ Sci B, 2019, 20(10): 781-792.
[28] Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol,2007, 4(5): 277-287.
[29] Out C, Patankar JV, Doktorova M, et al. Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4. J Hepatol, 2015, 63(3): 697-704.
[30] Degirolamo C, Rainaldi S, Bovenga F, et al. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep,2014, 7(1): 12-18.
[31] Pols TW, Noriega LG, Nomura M, et al. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol, 2011, 54(6): 1263-1272.
[32] Denton C, Price A, Friend J, et al. Role of the Gut?Liver Axis in Driving Parenteral Nutrition-Associated Injury. Children (Basel),2018, 5(10):136.
[33] Willis KA, Gomes CK, Rao P, et al. TGR5 signaling mitigates parenteral nutrition-associated liver disease. Am J Physiol Gastrointest Liver Physiol, 2020, 318(2): G322-G335.
[34] Deitch EA, Winterton J, Li M, et al. The gut as a portal of entry for bacteremia. Role of protein malnutrition. Ann Surg, 1987, 205(6): 681-692.
[35] Trauner M, Arrese M, Lee H, et al. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest, 1998, 101(10): 2092-2100.
[36] Madnawat H, Welu AL, Gilbert EJ, et al. Mechanisms of Parenteral Nutrition-Associated Liver and Gut Injury. Nutr Clin Pract, 2020, 35(1): 63-71.
[37] 吴青青,汤庆娅,蔡 威.含鱼油脂肪乳剂在儿童肠外营养相关性肝病的临床应用进展.肠外与肠内营养,2016,23(3):185-188.
相似文献/References:
[1]郑嘉烁.血流动力学不稳定的休克病人不宜早期使用肠内营养[J].肠外与肠内营养杂志,2019,(01):16.[doi:10.16151/j.1007-810x.2019.01.007]
[2]任 珊,龙 玲,赵浩天,等.河北省多家重症医学科医护人员营养治疗认知现状及分析[J].肠外与肠内营养杂志,2020,(05):285.[doi:10.16151/j.1007-810x.2020.04.007]
REN Shan,LONG Ling,ZHAO Hao-tian,et al.An Investigation on current practice of nutrition therapy for critically ill patients in Hebei ICUs[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):285.[doi:10.16151/j.1007-810x.2020.04.007]
[3]武 林,李梦璇,陈松林,等.肠外营养支持的克罗恩病病人导管相关性血流感染的风险因素研究[J].肠外与肠内营养杂志,2020,(05):298.[doi:10.16151/j.1007-810x.2020.04.010]
WU Lin,LI Meng-xuan,CHEN Song-lin,et al.Risk factors of catheter-related bloodstream infections in Crohn's disease patients receiving parenteral nutrition therapy[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):298.[doi:10.16151/j.1007-810x.2020.04.010]
[4]陈 维,杨达宇,孙景存,等.肠外营养个体化治疗在具有营养风险的晚期肺癌病人中的临床意义[J].肠外与肠内营养杂志,2020,(06):355.[doi:DOI : 10.16151/j.1007-810x.2020.06.008]
CHEN Wei,YANG Da-yu,SUN Jing-cun,et al.Clinical significance of individualized parenteral nutrition therapy in patients with advanced lung cancer and nutritional risk[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):355.[doi:DOI : 10.16151/j.1007-810x.2020.06.008]
[5]程 飞,翁延宏,陈 伟.早期肠内营养在急性胰腺炎病人中的应用分析[J].肠外与肠内营养杂志,2022,(03):150.[doi:DOI : 10.16151/j.1007-810x.2022.03.005]
CHENG Fei,WENG Yan-hong,CHEN Wei.Application of early enteral nutrition in acute pancreatitis[J].PARENTERAL & ENTERAL NUTRITION,2022,(06):150.[doi:DOI : 10.16151/j.1007-810x.2022.03.005]
[6]张 婷,马 鸣.儿童肠外营养液过敏反应个案报告并文献复习[J].肠外与肠内营养杂志,2022,(06):380.[doi:10.16151/j.1007-810x.2022.06.011]
[7]刘书颖,张连阳,王亚玲,等.一例小肠三造口病人消化液收集回输及营养支持护理[J].肠外与肠内营养杂志,2023,(04):254.[doi:DOI : 10.16151/j.1007-810x.2023.04.011]
[8]聂婧栩,崔凯霞,祁雪妍,等.肠外营养处方糖脂比合理范围重要性探讨[J].肠外与肠内营养杂志,2023,(05):257.[doi:10.16151/j.1007-810x.2023.05.001]
NIE Jing-xu,CUI Kai-xia,QI Xue-yan,et al.Discussion on importance of reasonable range of sugar-to-fat ratio in parenteral nutrition prescriptions[J].PARENTERAL & ENTERAL NUTRITION,2023,(06):257.[doi:10.16151/j.1007-810x.2023.05.001]
[9]沈 硕,赵雪成,宗厚琴,等.重症急性胰腺炎合并肠瘘病人早期营养支持治疗单中心回顾性研究[J].肠外与肠内营养杂志,2023,(05):270.[doi:10.16151/j.1007-810x.2023.05.003]
SHEN Shuo,ZHAO Xue-cheng,ZONG Hou-qin,et al.Current status of early nutritional support in patients with severe acute pancreatitis complicated with intestinal fistula[J].PARENTERAL & ENTERAL NUTRITION,2023,(06):270.[doi:10.16151/j.1007-810x.2023.05.003]